Darzalex 100 mg/5 mL (20 mg/mL) injection Images

Generic Name: daratumumab

This medication has been identified as Darzalex 100 mg/5 mL (20 mg/mL) injection. It is supplied by Janssen Biotech, Inc.

Darzalex is used in the treatment of Multiple Myeloma and belongs to the drug class CD38 monoclonal antibodies. Darzalex 100 mg/5 mL (20 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images of medication

Darzalex

Generic Name

daratumumab

Strength

100 mg/5 mL (20 mg/mL) injection

Availability

Prescription only

Drug Class

CD38 monoclonal antibodies

CSA Schedule

Not a controlled drug

Labeler / Supplier

Janssen Biotech, Inc.

National Drug Code (NDC)

57894-0502

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer